No abstract

No abstract

No abstract

Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre-including this research content-immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

Highlights:1. Telemedicine could emerge as a viable and effective option for managing patients with diabetes in the lockdown period requiring restrictions of travel. 2. Telemedicine includes a wide array of tools, and the choice depends on physician's or patient's ease of handling these tools and available technology. 3. In this article, we state simple principles of telemedicine directed towards management of patients with diabetes. Abstract:Background and Aims: In view of restrictions on mobility of patients because of COVID-19 pandemic, face-to-face consultations are difficult. We sought to study the feasibility of telemedicine in this scenario. Methods:PubMed database and Google Scholar were searched using the key terms 'telemedicine', 'diabetes', 'COVID-19'up to 31 ST March 2020. In addition, existing guidelines including those by Ministry of Health and Family Welfare (MOHFW), Government of India were accessed. Results:We discuss evidence and general guidelines regarding role of telemedicine in patients with diabetes along with its utility and limitations. Conclusions:Telemedicine is a useful tool for managing patients of diabetes during this lockdown period. However, there is limited data and further research is required.